CVS vs OGEN · P/E 16, rev $402.07B vs rev $37.7K
CVS Health Corp (CVS) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the CVS and OGEN stock pages for the full models.
Not investment advice.